[1]
Shabana Mohammad Ali 2024. Safety of Dapagliflozinin Reducing Cardiac Events and Deaths among NYHA Class II and III Cardiac Failure Patients. Pakistan Journal of Medical & Health Sciences. 18, 01 (Apr. 2024), 35. DOI:https://doi.org/10.53350/pjmhs0202418135.